Mark Scott Blumenkranz (born October 23,1950) is an American physician,surgeon,businessman,and entrepreneur. He is a trained ophthalmologist and vitreoretinal surgeon,and has served as H.J. Smead Professor and Chairman of Ophthalmology of the Byers Eye Institute at the Stanford University School of Medicine since 1997. He has founded or served on the Board of Directors of a number of companies,including Oculex,Peak Surgical,Optimedica Corporation,MacuSight,and Adverum Biotechnologies. In addition,he serves as a trustee of Brown University.[1]
Blumenkranz has founded a number of successful Silicon Valley start-up companies,beginning in the 1980s. Notably,he was on the Board of Directors of Oculex Pharmaceuticals,which was later sold to Allergan. He was on the board of directors of MacuSight,which was later sold to Santen,Inc. He was a founder and board member of OptiMedica Corporation (later sold to Abbott Medical Optics),Peak Surgical (later sold to Medtronic),and Adverum Biotechnologies.
Awards
Blumenkranz has won the American Academy of Ophthalmology Life Achievement Award (2008),the Foundation Fighting Blindness Visionary Award (2009),AOA Brown University (2011),and the AAO Jackson Memorial Lecture (2013).
Personal life
Blumenkranz is married to Recia Kott Blumenkranz,MD,and has three children,Carla,Scott,and Erik.
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.
